Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;21(6):746-748.
doi: 10.1016/S1473-3099(21)00020-7. Epub 2021 Feb 3.

Inactivated COVID-19 vaccines to make a global impact

Affiliations
Comment

Inactivated COVID-19 vaccines to make a global impact

Patrick L Iversen et al. Lancet Infect Dis. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Flanagan KL, Best E, Crawford NW, et al. Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines. Front Immunol. 2020;11 - PMC - PubMed
    1. WHO Draft landscape of COVID-19 candidate vaccines. Jan 15, 2021. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand...
    1. US Centers for Disease Control and Prevention COVID-19—older adults. Dec 13, 2020. http://cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults...
    1. Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(20)30987-7. published online Feb 3. - DOI - PMC - PubMed
    1. Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30843-4. published online Nov 17. - DOI - PMC - PubMed